Nwd1 gene linked to liver dysfunction in metabolic disease Skip to content Menu Medical Home Life Sciences Home Become a Member Search Medical Home Life Sciences Home About Functional Food News Health A-Z Drugs Medical Devices Interviews White Papers More... MediKnowledge eBooks Posters Podcasts Newsletters Health & Personal Care Contact Meet the Team Advertise Search Become a Member Top Health Categories Coronavirus Disease COVID-19 Diet & Nutrition Artificial Intelligence Allergies Alzheimer's & Dementia Arthritis & Rheumatology Breast Cancer Breastfeeding Cold, Flu & Cough Dermatology Diabetes Eating Disorders Eye Health Gastrointestinal Health Heart Disease Lung Cancer Mental Health Parkinson's Disease Pregnancy Sleep Urology View Health A-Z × Top Health Categories Coronavirus Disease COVID-19 Eating Disorders Diet & Nutrition Eye Health Artificial Intelligence Gastrointestinal Health Allergies Heart Disease Alzheimer's & Dementia Lung Cancer Arthritis & Rheumatology Mental Health Breast Cancer Parkinson's Disease Breastfeeding Pregnancy Cold, Flu & Cough Sleep Dermatology Urology Diabetes View Health A-Z Medical Home Life Sciences Home About News Life Sciences A-Z White Papers Lab Equipment Interviews Newsletters Webinars More... eBooks Posters Podcasts Contact Meet the Team Advertise Search Become a Member White Papers MediKnowledge eBooks Posters Podcasts Newsletters Health & Personal Care Contact Meet the Team Advertise Search Become a Member Webinars eBooks Posters Podcasts Contact Meet the Team Advertise Search Become a Member Nwd1 gene linked to liver dysfunction in metabolic disease Download PDF Copy Reviewed Waseda University Mar 11 2025 Metabolic dysfunction-associated steatohepatitis (MASH) is a liver disease that progresses without symptoms and is associated with significant global public health concerns. It is prevalent in 30% of the population worldwide and poses a risk of advancing to cirrhosis and liver cancer. MASH is marked by lipid droplet accumulation in the liver, progressing from steatosis to inflammation and cell damage, ultimately leading to fibrosis, cirrhosis, and hepatocellular carcinoma. A clear understanding of cellular processes in MASH pathogenesis is essential for developing targeted therapies. A key factor in the pathology of MASH is the disruption of endoplasmic reticulum (ER) homeostasis. The ER stores calcium ions (Ca 2+ ) and plays a crucial role in regulating protein folding, lipid transfer, and organelle dynamics. The accumulation of unfolded or misfolded proteins in the ER activates a series of homeostatic responses known as ER stress, and sustained ER stress plays a role in the development of MASH. Recent studies indicate that the dysfunction of sarco/ER calcium ATPase (SERCA2), which regulates Ca 2+ transport to the ER, can also induce ER stress, contributing to MASH. In addition to SERCA2, previous research on NACHT and WD repeat domain-containing protein 1 ( Nwd1 ) gene, which is part of the signal transduction ATPase family, has shown that it is localized in the ER and is expressed in both the liver and the brain. However, the role of the Nwd1 gene in SERCA2 activity and the pathogenesis of MASH remains unclear. In a recent study, published on March 11, 2025, in Communications Biology , a team of scientists led by Professor Shin-ichi Sakakibara from the Laboratory for Molecular Neurobiology, Faculty of Human Sciences, Waseda University, Japan, explored the physiological role of Nwd1 in MASH pathogenesis. "The full mechanism behind the development of MASH remains unclear, and currently, only one therapeutic drug has been approved. Therefore, this study aimed to investigate the role of the Nwd1 gene in liver pathogenesis to identify potential new therapeutic targets. Our research is the first to explore the role of Nwd1 outside of the brain," says Dr. Sakakibara. The team created a Nwd1 knockout ( Nwd1 −/− ) mice model using the CRISPR-Cas9 genome editing technique. They subsequently investigated the effects of Nwd1 deficiency on liver function and various cellular processes. The scientists found that Nwd1 −/− mice exhibited liver pathologies, including excessive lipid accumulation, fibrosis, and heightened ER stress, mirroring MASH. Additionally, they saw a rise in pyroptosis-a form of programmed inflammatory cell death-in the livers of Nwd1 −/− mice. Elevated levels of cleaved caspase-1 and increased leukocyte counts were also observed, indicating heightened inflammatory responses that further exacerbated liver damage. The researchers also discovered that Nwd1 interacts with SERCA2. They found that in the absence of Nwd1 , SERCA2 activity was significantly reduced, leading to diminished ER Ca 2+ storage and intensified ER stress. This stress was directly linked to the accumulation of lipid droplets in hepatocytes, a hallmark of MASH. Related Stories Global trends shape progress in cell and gene therapies Scientists create new map showing how cancer gene mutations influence tumor growth SynGenSys introduces Liver.SET synthetic promoter library for liver-specific gene expression for in vivo gene therapies The first co-author, Dr. Seiya Yamada, stated, "These findings position Nwd1 as a potential regulator of liver homeostasis, particularly through its role in maintaining ER function and calcium balance." Overall, by demonstrating how Nwd1 deficiency disrupts these processes, the study offers fresh insights into MASH pathogenesis and underscores the therapeutic potential of targeting ER stress pathways. "With MASH lacking effective treatments, understanding the molecular underpinnings of its development is crucial. This study paves the way for future research exploring Nwd1 as a therapeutic target, potentially leading to novel strategies to combat this growing public health issue," concludes Dr. Yamada. Source: Waseda University Journal reference: Yamada, S. , et al. (2025). Induction of MASH-like pathogenesis in the Nwd1−/− mouse liver. Communications Biology . doi.org/10.1038/s42003-025-07717-5 . Posted in: Medical Research News | Medical Condition News Comments (0) Download PDF Copy Suggested Reading Protrusion-derived extracellular vesicles boost functional cargo transfer New workflow boosts nuclear delivery for safer gene therapy Blood gene signals reveal Parkinson’s risk years before diagnosis New gene editing approach offers hope for cystic fibrosis patients Lund's new model aims to accelerate patient access to cell and gene therapies Chronic alcohol use profoundly alters gene expression in the brain's reward system Cellares to expand automated manufacturing to gene-edited stem cell therapies Causal gene mapping identifies key drivers of Alzheimer's disease progression Comments The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical. Cancel reply to comment Post a new comment Login (Logout) Quirky Comment Title Post Trending Stories Latest Interviews Top Health Articles Case report examines potential cancer risks after mRNA vaccination Study uncovers immune trigger behind vaccine-induced immune thrombocytopenia and thrombosis Nasal COVID vaccine boost increases IgA responses linked to variant neutralisation Researchers identify a previously unknown cellular barrier in the brain Ozempic users continue treatment when weight loss works despite side effects Advancing brain microphysiological systems (bMPS) Dr. Lena Smirnova Brain microphysiological systems are reshaping in vitro neurotoxicity testing through functional validation and advanced disease modeling. PhD researcher at LifeArc Natasha Bury Targeted protein degradation presents a promising strategy to address antimicrobial resistance, focusing on innovative approaches for gram-negative bacteria. Unveiling Hidden Potential: Organoids for Disease Modeling in Neuroscience Research Rosanna Zhang In our latest interview, News-Medical speaks with Rosanna Zhang from ACROBiosystems about utilizing organoids for disease modeling in the field of neuroscience research. Astaxanthin and Human Health: Evidence on Skin, Vision, Brain, and Aging The Gut–Brain–Skin Axis: How Diet and Gut Health Influence Mood, Skin, and Aging How Morning Routines Influence Cognitive Performance, Mood, and Circadian Rhythm Camel Milk Nutrition Facts and Potential Health Benefits Explained Edible Insects as Food: Nutritional Benefits, Safety, and Environmental Impact Latest News Researchers discover a way to breach cancer’s impenetrable fortress Weekend holiday rehabilitation supports recovery in elderly hip fracture patients Novel implant delivers tiny growth-promoting particles directly to injured nerve cells Changes in lymphatic vessels can help identify aggressive oral cancer at an early stage Axol Bioscience acquires ophthalmology business from Newcells Biotech Newsletters you may be interested in Genetics ( Subscribe or Preview ) Neurology & Neuroscience ( Subscribe or Preview ) Hepatology ( Subscribe or Preview ) See all Newsletters » High Credibility: This website adheres to all nine standards of credibility and transparency. Medical Links Medical Home Functional Food News Health A-Z White Papers Thought Leaders Insights MediKnowledge Series Health & Personal Care Medical Devices Drugs eBooks Posters Podcasts Life Sciences Links Life Sciences Home News Lab Instruments & Equipment Life Sciences A-Z White Papers Thought Leaders Insights Webinars eBooks Posters Podcasts Other Useful Links About Meet the Team Search Newsletters Sitemap Advertise Contact Terms & Conditions Privacy & Cookie Policy Content Policy Ownership & Funding Information Other AZoNetwork Sites AZoM AZoNano AZoCleantech AZoOptics AZoRobotics AZoSensors AZoMining AZoQuantum AZoBuild AZoLifeSciences AZoAi Facebook Twitter LinkedIn News-Medical.Net provides this medical information service in accordance with these terms and conditions . Please note that medical information found on this website is designed to support, not to replace the relationship between patient and physician/doctor and the medical advice they may provide. Update Your Privacy Preferences Last Updated: Wednesday 18 Feb 2026 News-Medical.net - An AZoNetwork Site Owned and operated by AZoNetwork, © 2000-2026 Azthena logo with the word Azthena Maximise chat window Hide chat window Your AI Powered Scientific Assistant Hi, I'm Azthena, you can trust me to find commercial scientific answers from News-Medical.net. To start a conversation, please log into your AZoProfile account first, or create a new account. Registered members can chat with Azthena, request quotations, download pdf's, brochures and subscribe to our related newsletter content . Log in A few things you need to know before we start. Please read and accept to continue. Use of “Azthena” is subject to the terms and conditions of use as set out by OpenAI . Content provided on any AZoNetwork sites are subject to the site Terms & Conditions and Privacy Policy . Large Language Models can make mistakes. Consider checking important information. I understand, and agree to receive occasional emails about Azthena such as usage tips and new feature announcements. Please check the box above to proceed. Start Chat Great. Ask your question. Clear Chat Clear Chat Brief Moderate Detailed Azthena may occasionally provide inaccurate responses. Read the full terms . Terms While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided. Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles. Please do not ask questions that use sensitive or confidential information. Read the full Terms & Conditions . Provide Feedback Submit Cancel You might also like... × First topical CRISPR gene therapy corrects disease-causing mutations in human skin